High Flow Oxygen Therapy Devices Market: Global Industry Trend Analysis 2013 to 2017 and Forecast 20
Actualizado: 26 sept 2018
Recently has been published the report on the High-Flow Nasal Cannula Market. This report analyzes the current and future scenario of the global market. High flow therapy has emerged as an innovative respiratory technique, and, in opinión of authors, is expected to replace the conventional low-flow oxygen therapy and other non-invasive ventilation techniques for the treatment of respiratory diseases. Therefore, the rising incidence of respiratory disorders leading to the increasing number of people requiring oxygen therapy is expected to drive the high-flow nasal cannula market.
The market is growing with the introduction of advanced high flow oxygen therapy devices which offers efficient patient care that is expected to boost the market. The high flow oxygen therapy device is intended to eliminate the work load related to the procedure involved. Main target clinical indication it is used for is COPD, Bronchiectasis, Mucociliary Disfunction, Oxygen Therapy, Chronic cough, Tracheostomy, Obstructive Pulmonary Disease. The mentioned factors are expected to propel the high flow oxygen therapy devices and lead to further expansion in technology used. Increasing pollution is leading to a more unsafe environment to breathe in, causing more no. cases associated with respiratory problems which happens to be a major point for the high oxygen flow therapy devices market to grow.
The high-flow nasal cannula market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global high-flow nasal cannula market with respect to the segments based on application, component, end user and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porter’s five forces analysis and value chain analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global high-flow nasal cannula market. I would like to comment some aspects of the report.
Based on component, high-flow nasal cannulas market is segmented into air/oxygen blender, active humidifier, single heated tube, nasal cannulas and other consumables. The market segments have been extensively analyzed based on availability of different high-flow nasal cannula components, product variations available and average price high-flow nasal cannula system. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on application, the high-flow nasal cannula market is segmented as acute respiratory failure, chronic obstructive pulmonary disease (COPD), acute heart failure, carbon monoxide toxicity, sleep apnea, bronchiectasis and other applications. The application market segments have been analyzed based on incidences of the disease and preference for use high-flow nasal cannula among patients. Among applications, the acute respiratory failure segment accounted for a prominent share of the global high-flow nasal cannula market in 2016 whereas the sleep apnea segment is expected to register the maximum CAGR during the forecast period. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.Based on end user, high-flow nasal cannulas market is segmented into hospitals, long-term care centers, ambulatory care centers and other end-users. The market segments have been extensively analyzed based on variations of cannulas provided by the healthcare providers and preference of the patients for the treatment facility. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Geographically, the global high-flow nasal cannula market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.
The report also profiles major players in the global high-flow nasal cannula market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Fisher & Paykel Healthcare Limited, ResMed, Inc., Teijin Pharma Limited, Becton, Dickinson and Company, MEK-ICS CO., LTD., Teleflex Incorporated, Smiths Medical, Vapotherm, Inc., Flexicare Medical Limited, Salter Labs, Hamilton Medical TNI medical AG, Great Group Medical Co., Ltd., and others.
The positive expectations of Global Industry Trend Analysis 2013 to 2017 and Forecast 2018 – 2026 are are in line with the expansion of the therapy in the real clinical world.